DrugPatentWatch Database Preview
Hong Kong Company Profile
What is the competitive landscape for HONG KONG, and what generic and branded alternatives to HONG KONG drugs are available?
HONG KONG has four approved drugs.
Summary for Hong Kong
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Hong Kong
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hong Kong | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 205696-001 | Jul 17, 2018 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Hong Kong | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 206190-001 | Nov 9, 2017 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Hong Kong | TOPOTECAN HYDROCHLORIDE | topotecan hydrochloride | INJECTABLE;INJECTION | 201166-001 | Aug 8, 2012 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Hong Kong | BLEOMYCIN SULFATE | bleomycin sulfate | INJECTABLE;INJECTION | 205030-001 | Apr 20, 2018 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Hong Kong | BLEOMYCIN SULFATE | bleomycin sulfate | INJECTABLE;INJECTION | 205030-002 | Apr 20, 2018 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
